Chitosan Powder Pharmaceutical Grade (CHT-95)

Description

1. Product Overview

Chitosan Powder Pharmaceutical Grade (CHT-95) is a high-purity, deacetylated polysaccharide derived from chitin and engineered for pharmaceutical, healthcare, nutraceutical, and advanced biomedical applications. Its biocompatibility, film-forming capability, biodegradability, and functional amino groups make it a versatile material for formulation, encapsulation, controlled-release systems, and specialty pharmaceutical processing. CHT-95 offers industrial buyers a consistent pharmaceutical-grade raw material designed to support stringent quality requirements and reliable downstream processing. As demand increases for biodegradable and functional biomaterials, pharmaceutical-grade chitosan represents a strategically important alternative to conventional synthetic excipients and specialty polymers.

2. Key Specifications & Technical Characteristics

• Product: Chitosan Powder Pharmaceutical Grade (CHT-95)
• Chemical Composition: Deacetylated chitin-derived polysaccharide composed primarily of β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine units
• Degree of Deacetylation: Approximately 95%, subject to batch specification
• Grade: Pharmaceutical Grade
• Purity: High-purity material suitable for pharmaceutical and nutraceutical processing, with detailed assay and impurity specifications available by batch
• Physical Form: Fine powder
• Color: Typically white to off-white or pale cream
• Solubility: Generally soluble or dispersible in dilute acidic media; performance depends on molecular weight, degree of deacetylation, and formulation conditions
• Particle Size: Customizable/available according to buyer specification and application requirements
• Molecular Weight: Available in controlled molecular-weight ranges according to application requirements
• Packaging Options: 20–25 kg fiber drums, HDPE-lined bags, or customized industrial packaging
• Shelf Life: Typically up to 24 months when stored in a cool, dry environment in tightly sealed original packaging, subject to supplier specification
• Storage: Protect from moisture, heat, direct sunlight, and contamination; maintain in sealed packaging under recommended storage conditions
• Documentation: Certificate of Analysis (CoA), specification sheet, Safety Data Sheet (SDS), and applicable quality documentation available upon request

3. Core Industrial Applications

• Pharmaceutical Formulation: Used as a functional excipient, matrix-forming material, film former, and carrier in pharmaceutical formulations and controlled-release delivery systems.
• Drug Delivery: Supports encapsulation, microsphere formation, nanoparticle systems, and targeted or sustained-release technologies due to its functional amino groups and biocompatibility.
• Wound-Care Materials: Utilized in advanced wound dressings, films, gels, and other biomedical materials where biodegradability and film-forming performance are commercially valuable.
• Nutraceuticals & Functional Ingredients: Applied in specialty nutraceutical formulations and encapsulation technologies requiring a naturally derived functional polymer.
• Biomedical Materials: Suitable for research and commercial development of scaffolds, coatings, membranes, and other biocompatible polymer systems.
• Cosmetic & Personal Care Formulation: Used in selected specialty formulations requiring film-forming, conditioning, or functional polymer characteristics.
• Industrial Advantage: Compared with many conventional synthetic polymers, chitosan offers a renewable biological origin, biodegradability, and versatile chemical functionality, supporting development of higher-value pharmaceutical and biomedical products.

4. Competitive Advantages

• Quality Consistency: Controlled degree of deacetylation and pharmaceutical-grade processing support reproducible formulation and downstream performance.
• High Functional Value: Approximately 95% deacetylation provides a high concentration of reactive amino groups for formulation and material-engineering applications.
• Supply Reliability: Structured bulk supply programs support continuous procurement for pharmaceutical, nutraceutical, and specialty-material manufacturers.
• Logistics Capability: Bulk packaging and export-oriented shipment options facilitate containerized international distribution and industrial-scale sourcing.
• Price Competitiveness: Bulk procurement enables cost optimization while maintaining pharmaceutical-grade material specifications.
• Sustainability: Chitosan is derived from naturally occurring chitin and offers biodegradability, providing an attractive material platform for manufacturers pursuing more sustainable product-development strategies.
• Technical Documentation: CoA, SDS, product specifications, and relevant quality documentation can support supplier qualification, incoming-material inspection, and regulatory review.
• Strategic Sourcing Value: CHT-95 combines high functional performance, renewable origin, pharmaceutical-grade positioning, and scalable bulk availability, making it a strategic raw-material option for manufacturers seeking dependable specialty polymer supply.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK — 20 MT
• Loading Capacity: Up to approximately 20 MT per container, subject to packaging configuration, container payload limits, and destination requirements